The gastrointestinal tract microbiome and potential link to Alzheimer's disease

Frontiers in Neurology

Volumn 5 APR, Issue , 2014, Pages

  Hill, James M ^a,b   Bhattacharjee, Surjyadipta ^a   Pogue, Aileen I ^c   Lukiw, Walter J ^a,b,c  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Alchem Biotek Corporation   (Canada)

Author keywords

Alzheimer's disease; Bacteroidetes; BDNF; BMAA; Evolution; Firmicutes; Genetic complexity; Microbiome

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; 4 AMINOBUTYRIC ACID; ANATOXIN A; BRAIN DERIVED NEUROTROPHIC FACTOR; N METHYL DEXTRO ASPARTIC ACID; SAXITOXIN;

ALZHEIMER DISEASE; ARTICLE; AUTOIMMUNITY; AUTONOMIC NERVOUS SYSTEM; BIFIDOBACTERIUM; BIFIDOBACTERIUM DENTIUM; CYANOBACTERIUM; DISEASE ASSOCIATION; ENDOCYTOBIOSIS; GNOTOBIOTICS; INTESTINE FLORA; INTESTINE INNERVATION; LACTOBACILLUS BREVIS; MICROBIOME; NERVE CELL PLASTICITY; NONHUMAN;

EID: 84901027290     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00043     Document Type: Article

References (54)

1. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA (1998) 95:6578-83. doi: 10.1073/pnas.95.12.6578.
2. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 444:1027-31. doi:10.1038/nature05414.
3. Bravo JA, Julio-Pieper M, Forsythe P, Kunze W, Dinan TG, Bienenstock J, et al. Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol (2012) 12(6):667-72. doi:10.1016/j.coph.2012.09.010.
4. Bhattacharjee S, Lukiw WJ. Alzheimer's disease and the microbiome. Front Cell Neurosci (2013) 7:153. doi:10.3389/fncel.2013.00153.
5. Albenberg LG, Wu GD. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology (2014). doi:10.1053/j.gastro.2014.01.058.
6. Zoetendal EG, de Vos WM. Effect of diet on the intestinal microbiota and its activity. Curr Opin Gastroenterol (2014) 30:189-95. doi:10.1097/MOG.0000000000000048.
7. Kim BS, Jeon YS, Chun J. Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr (2013) 16:71-9. doi:10.5223/pghn.2013.16.2.71.
8. Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol (2014). doi:10.1097/MCG.0000000000000046.
9. Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M. Role of "Western diet" in inflammatory autoimmune diseases. Curr Allergy Asthma Rep (2014) 14:404. doi:10.1007/s11882-013-0404-6.
10. Pamer EG. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol (2014) 7:210-4. doi:10.1038/mi.2013.117.
11. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science (2005) 307:1915-20. doi:10.1126/science.1104816.
12. Boutajangout A, Wisniewski T. The innate immune system in Alzheimer's disease. Int J Cell Biol (2013) 2013:576383. doi:10.1155/2013/576383.
13. Brenner SR. Blue-green algae or cyanobacteria in the intestinal micro-flora my produce neurotoxins such as beta-N-methylamino-L-alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinsons-Dementia-Complex in humans and equine motor neuron disease in horses. Med Hypotheses (2013) 80(1): 103-8. doi:10.1016/j.mehy.2012.10.010.
14. Douglas-Escobar M, Elliott E, Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr (2013) 167:374-9. doi:10.1001/jamapediatrics.2013.497.
15. Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA (2011) 108:3047-52. doi:10.1073/pnas.1010529108.
16. Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil (2013) 25:4-15. doi:10.1111/nmo.12046.
17. Camfield DA, Owen L, Scholey AB, Pipingas A, Stough C. Dairy constituents and neurocognitive health in ageing. Br J Nutr (2011) 106:159-74. doi:10.1017/S0007114511000158.
18. Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol (2013) 16(3):240-5. doi:10.1016/j.mib.2013.06.004.
19. Forsythe P, Kunze WA, Bienenstock J. On communication between gut microbes and the brain. Curr Opin Gastroenterol (2012) 28:557-62. doi:10.1097/MOG.0b013e3283572ffa.
20. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci (2013) 36:305-12. doi:10.1016/j.tins.2013.01.005.
21. Schwartz K, Boles BR. Microbial amyloids-functions and interactions within the host. Curr Opin Microbiol (2013) 16:93-9. doi:10.1016/j.mib.2012.12.001.
22. Lukiw WJ, Bazan NG. Survival signaling in Alzheimer's disease. Biochem Soc Trans (2006) 34:1277-82. doi:10.1042/BST0341277.
23. Hornig M. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol (2013) 25:488-795. doi:10.1097/BOR.0b013e32836208de.
24. Udit S, Gautron L. Molecular anatomy of the gut-brain axis revealed with transgenic technologies: implications in metabolic research. Front Neurosci (2013) 7:134. doi:10.3389/fnins.2013.00134.
25. McVey Neufeld KA, Mao YK, Bienenstock J, Foster JA, Kunze WA. The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol Motil (2013) 25(2):183-e88. doi:10.1111/nmo.12049.
26. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol (2012) 113:411-7. doi:10.1111/j.1365-2672.2012.05344.x.
27. Mitew S, Kirkcaldie MT, Dickson TC, Vickers JC. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice. Neurobiol Aging (2013) 34:2341-51. doi:10.1016/j.neurobiolaging.2013.04.010.
28. Paula-Lima AC, Brito-Moreira J, Ferreira ST. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease. J Neurochem (2013) 126:191-202. doi:10.1111/jnc.12304.
29. Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2013) 4:17-27. doi:10.4161/gmic.22973.
30. Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol (2013) 70:1158-66. doi:10.1001/jamaneurol.2013.136.
31. Carlino D, De Vanna M, Tongiorgi E. Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunction? Neuroscientist (2013) 19:345-53. doi:10.1177/1073858412469444.
32. Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci (2013) 14:401-16. doi:10.1038/nrn3505.
33. Murphy MC, Fox EA. Mice deficient in brain-derived neurotrophic factor have altered development of gastric vagal sensory innervation. J Comp Neurol (2010) 518(15):2934-51. doi:10.1002/cne.22372.
34. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A (2011) 108(38):16050-5. doi:10.1073/pnas.1102999108.
35. Lakhan SE, Caro M, Hadzimichalis N. NMDA receptor activity in neuropsychiatric disorders. Front Psychiatry (2013) 4:52. doi:10.3389/fpsyt.2013.00052.
36. Mulligan VK, Chakrabartty A. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis. Proteins (2013) 81:1285-303. doi:10.1002/prot.24285.
37. Tran L, Greenwood-Van Meerveld B. Age-associated remodeling of the intestinal epithelial barrier. J Gerontol A Biol Sci Med Sci (2013) 68:1045-56. doi:10.1093/gerona/glt106.
38. Asti A, Gioglio L. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? J Alzheimers Dis (2014) 39:169-79. doi:10.3233/JAD-131394.
39. Ball MJ, Lukiw WJ, Kammerman EM, Hill JM. Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement (2013) 9:169-75. doi:10.1016/j.jalz.2012.07.005.
40. Zhao Y, Bhattacharjee S, Jones BM, Dua P, Alexandrov PN, Hill JM, et al. Regulation of TREM2 expression by an NF-κB-sensitive miRNA-34a. Neuroreport (2013) 24:318-23. doi:10.1097/WNR.0b013e32835fb6b0.
41. Zhao Y, Lukiw WJ. TREM2 signaling, miRNA-34a and the extinction of phagocytosis. Front Cell Neurosci (2013) 7:131. doi:10.3389/fncel.2013.00131.
42. Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim Biophys Acta (1995) 1271(1):111-21. doi:10.1016/0925-4439(95)00017-X.
43. Hill JM, Ball MJ, Neumann DM, Azcuy AM, Bhattacharjee PS, Bouhanik S, et al. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol (2008) 82:8230-4. doi:10.1128/JVI.00686-08.
44. Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe (2010) 16:444-53. doi:10.1016/j.anaerobe.2010.06.008.
45. Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R. Parkinson disease: the enteric nervous system spills its guts. Neurology (2011) 77:1761-7. doi:10.1212/WNL.0b013e318236ef60.
46. Cersosimo MG, Raina GB, Pecci C, Pellene A, Calandra CR, Gutiérrez C, et al. Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms. J Neurol (2013) 260:1332-8. doi:10.1007/s00415-012-6801-2.
47. Lukiw WJ. Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD), "Regulatory RNAs in the Nervous System". Front Cell Neurosci (2013) 7:133. doi:10.3389/fncel.2013.00133.
48. Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell (2012) 148:1204-22. doi:10.1016/j.cell.2012.02.040.
49. Souslova T, Marple TC, Spiekerman AM, Mohammad AA. Personalized medicine in Alzheimer's disease and depression. Contemp Clin Trials (2013) 36:616-23. doi:10.1016/j.cct.2013.06.012.
50. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev (2006) 19:80-94. doi:10.1128/CMR.19.1.80-94.2006.
51. Hayashi M. Anti-basal ganglia antibody. Brain Nerve (2013) 65(4):377-84.
52. Semar S, Klotz M, Letiembre M, Van Ginneken C, Braun A, Jost V, et al. Changes, of the enteric nervous system in amyloid-β protein precursor transgenic mice, correlate with disease progression. J Alzheimers Dis (2013) 36:7-20. doi:10.3233/JAD-120511.
53. Singh VP, Sharma J, Babu S, Rizwanulla Singla A. Role of probiotics in health and disease: a review. J Pak Med Assoc (2013) 63:253-7.
54. Tuohy KM, Fava F, Viola R. 'The way to a man's heart is through his gut microbiota'-dietary pro-and prebiotics for the management of cardiovascular risk. Proc Nutr Soc (2014) 4:1-14. doi:10.1017/S0029665113003911.